Novaliq strengthens executive management team with the appointment of Gabriela Burian, MD, MPH, as consulting chief medical officer

NOVALIQ GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, today announced the appointment of Gabriela Burian, MD, MPH, as Consulting Chief Medical Officer (CMO). Dr. Burian brings over 25 years of international clinical experience to the company. She is responsible for leading…